home All News open_in_new Full Article

Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT

Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)  The Manila Times


today 4 d. ago attach_file Events

attach_file Politics
attach_file Culture
attach_file Economics
attach_file Culture
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Science
attach_file Sport
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Science
attach_file Science
attach_file Events


ID: 3782624638
Add Watch Country

arrow_drop_down